Maciag PC - Search Results

1

Listeria-based vaccines for cancer treatment.

Paterson Y, Maciag PC. Paterson Y, et al. Among authors: maciag pc. Curr Opin Mol Ther. 2005 Oct;7(5):454-60. Curr Opin Mol Ther. 2005. PMID: 16248280 Review.

2

Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases.

Kim SH, Castro F, Gonzalez D, Maciag PC, Paterson Y, Gravekamp C. Kim SH, et al. Among authors: maciag pc. Br J Cancer. 2008 Sep 2;99(5):741-9. doi: 10.1038/sj.bjc.6604526. Epub 2008 Aug 19. Br J Cancer. 2008. PMID: 18728665 Free PMC article.

3

Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human.

Shahabi V, Seavey MM, Maciag PC, Rivera S, Wallecha A. Shahabi V, et al. Among authors: maciag pc. Cancer Gene Ther. 2011 Jan;18(1):53-62. doi: 10.1038/cgt.2010.48. Epub 2010 Aug 20. Cancer Gene Ther. 2011. PMID: 20725099

4

Therapeutic cancer vaccines in cervical cancer: phase I study of Lovaxin-C.

Radulovic S, Brankovic-Magic M, Malisic E, Jankovic R, Dobricic J, Plesinac-Karapandzic V, Maciag PC, Rothman J. Radulovic S, et al. Among authors: maciag pc. J BUON. 2009 Sep;14 Suppl 1:S165-8. J BUON. 2009. PMID: 19785060 Clinical Trial.

5

Development of a Listeria monocytogenes based vaccine against prostate cancer.

Shahabi V, Reyes-Reyes M, Wallecha A, Rivera S, Paterson Y, Maciag P. Shahabi V, et al. Cancer Immunol Immunother. 2008 Sep;57(9):1301-13. doi: 10.1007/s00262-008-0463-z. Epub 2008 Feb 14. Cancer Immunol Immunother. 2008. PMID: 18273616

6

Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy.

Wallecha A, Maciag PC, Rivera S, Paterson Y, Shahabi V. Wallecha A, et al. Among authors: maciag pc. Clin Vaccine Immunol. 2009 Jan;16(1):96-103. doi: 10.1128/CVI.00274-08. Epub 2008 Nov 19. Clin Vaccine Immunol. 2009. PMID: 19020110 Free PMC article.

7

Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.

Wallecha A, Carroll KD, Maciag PC, Rivera S, Shahabi V, Paterson Y. Wallecha A, et al. Among authors: maciag pc. Adv Appl Microbiol. 2009;66:1-27. doi: 10.1016/S0065-2164(08)00801-0. Adv Appl Microbiol. 2009. PMID: 19203646 Review.

8

Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization.

Mustafa W, Maciag PC, Pan ZK, Weaver JR, Xiao Y, Isaacs SN, Paterson Y. Mustafa W, et al. Among authors: maciag pc. Viral Immunol. 2009 Jun;22(3):195-204. doi: 10.1089/vim.2008.0071. Viral Immunol. 2009. PMID: 19435416 Free PMC article.

9

Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.

Maciag PC, Seavey MM, Pan ZK, Ferrone S, Paterson Y. Maciag PC, et al. Cancer Res. 2008 Oct 1;68(19):8066-75. doi: 10.1158/0008-5472.CAN-08-0287. Cancer Res. 2008. PMID: 18829565 Free PMC article.

10

Technology evaluation: HspE7 (Stressgen).

Maciag PC, Paterson Y. Maciag PC, et al. Curr Opin Mol Ther. 2005 Jun;7(3):256-63. Curr Opin Mol Ther. 2005. PMID: 15977424 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results